Intradermal Micro-Dosing of AbobotulinumtoxinA for Face-Lifting: How Long Does It Last?
Abstract Introduction Intradermal injection of botulinum toxin type A (BoNT/A) has been used off-label by many clinicians for face-lifting. Previous studies on abobotulinumtoxinA (ABO) (Dysport®; Ipsen Biopharm Ltd.) have demonstrated clinical efficacy in face-lifting when compared to normal saline...
Main Authors: | Rungsima Wanitphakdeedecha, Chadakan Yan, Chalermkwan Apinuntham, Viboon Rojanavanich, Kathryn Anne G. Cembrano, Sasima Eimpunth, Woraphong Manuskiatti |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2020-06-01
|
Series: | Dermatology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s13555-020-00414-7 |
Similar Items
-
Effectiveness of AbobotulinumtoxinA in Post-stroke Upper Limb Spasticity in Relation to Timing of Treatment
by: Jörg Wissel, et al.
Published: (2020-02-01) -
Use of AbobotulinumtoxinA in Adults with Cervical Dystonia: A Systematic Literature Review
by: Alfonso Fasano, et al.
Published: (2020-07-01) -
Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom
by: Muthukumar M, et al.
Published: (2017-04-01) -
Use of AbobotulinumtoxinA for Cosmetic Treatments in the Neck, and Middle and Lower Areas of the Face: A Systematic Review
by: Hassan Galadari, et al.
Published: (2021-02-01) -
Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies
by: Alberto Esquenazi, et al.
Published: (2020-09-01)